Liu Yuantao, Li Jun, Jin Hongyan, Lu Ying, Lu Xin
Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China.
Oncol Lett. 2013 Jan;5(1):267-270. doi: 10.3892/ol.2012.943. Epub 2012 Sep 27.
Synchronous primary endometrial and ovarian cancers are uncommon. The purpose of this study was to evaluate the clinicopathological characteristics, treatment and prognosis of synchronous primary endometrial and ovarian cancers. The clinicopathological characteristics of 43 patients with synchronous primary endometrial and ovarian cancers in the Obstetrics and Gynecology Hospital of Fudan University between 1999 and 2009 were retrospectively reviewed. Our results revealed that the median age at the time of diagnosis was 51 years (range, 29-71). The common presenting symptoms were abnormal uterine bleeding (AUB, 65.12%), abdominal mass (25.58%), abdominal pain and abdominal fullness (39.53%). An elevated CA125 level was observed in the majority of patients (n=20, 76.9%). Endometrioid type accounted for 60.47% of uterine carcinomas and different pathological types, including serous adenocarcinoma, clear cell carcinoma, adenosquamous and acanthoadenocarcinoma, were also identified in synchronous primary endometrial and ovarian cancers. All patients underwent surgical intervention (hysterectomy and bilateral salpingo-oophorectomy with pelvic lymphadenectomy or debulking surgery). The 5-year survival rate was 86.05% and nine patients had recurrence (20.93%). The early stage group (FIGO stages I and II) had more favorable prognosis than the advanced stage group (FIGO stages III and IV; P<0.05). In conclusion, synchronous primary endometrial and ovarian cancers are different from either primary endometrial carcinoma or ovarian cancer and are usually identified at early stages with a good prognosis.
同步性原发性子宫内膜癌和卵巢癌并不常见。本研究的目的是评估同步性原发性子宫内膜癌和卵巢癌的临床病理特征、治疗及预后。回顾性分析了1999年至2009年期间复旦大学附属妇产科医院43例同步性原发性子宫内膜癌和卵巢癌患者的临床病理特征。我们的结果显示,诊断时的中位年龄为51岁(范围29 - 71岁)。常见的临床表现为异常子宫出血(AUB,65.12%)、腹部肿块(25.58%)、腹痛和腹胀(39.53%)。大多数患者(n = 20,76.9%)CA125水平升高。子宫内膜样型占子宫癌的60.47%,同步性原发性子宫内膜癌和卵巢癌中还发现了不同的病理类型,包括浆液性腺癌、透明细胞癌、腺鳞癌和棘腺癌。所有患者均接受了手术干预(子宫切除术、双侧输卵管卵巢切除术加盆腔淋巴结清扫术或肿瘤细胞减灭术)。5年生存率为86.05%,9例患者复发(20.93%)。早期组(FIGO分期I和II期)的预后比晚期组(FIGO分期III和IV期;P<0.05)更有利。总之,同步性原发性子宫内膜癌和卵巢癌不同于原发性子宫内膜癌或卵巢癌,通常在早期被发现,预后良好。